References
- 1. Perheentupa J. Autoimmune polyendocrinopathy-candidiasisectodermal dystrophy. J Clin Endocrinol Metab 2006; 91: 2843-50.
- 2. Podkrajsek KT, Bratanic N, Krzisnik C, Battelino T. Autoimmune regulator-1 messenger ribonucleic acid analysis in a novel intronic mutation and two additional novel AIRE gene mutations in a cohort of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. J Clin Endocrinol Metab 2005; 90: 4930-5.
- 3. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M. et al. Positional cloning of the APECED gene. Nat Genet 1997; 17: 393-8.
- 4. Liston A, Lasage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specific T-cells. Nat Immunol 2003; 4: 350-4.
- 5. Peterson P, Peltonen L. Autoimmune polyglandular syndrome type 1 (APS1) and AIRE gene: new views on molecular basis od autoimmunity. J Autoimmun 2005; 25: 49-55.
- 6. Meager A, Visvalingam K, Peterson P, Möll K, Murumägi A, Krohn K. et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 2006; 3: e289.
- 7. Kisand K, Bøe Wolff AS, Podkrajsek KT, Tserel L, Link M, Kisand KV. et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med 2010; 207: 299-308.
- 8. Podkrajsek KT, Milenković T, Odink RJ, Claasen-van der Grinten HL, Bratanic N, Hovnik T. et al. Detection of a complete autoimmune regulator gene deletion and two additional novel mutations in a cohort of patients with atypical phenotypic variants of autoimmune polyglandular syndrome type 1. Eur J Endocrinol 2008; 159: 633-9.
- 9. Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J. Clinical variation of autoimmune -polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990; 322: 1829-36.
- 10. Kärner J, Meager A, Laan M, Maslovskaja J, Pihlap M, Remm A. et al. Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice.Clin Exp Immunol 2013; 171: 263-72.
- 11. Millar S, Carson D. Clinical phenotypes of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy seen in the Northern Ireland paediatric population over the last 30 years. Ulster Med J 2012; 81: 118-22.
- 12. Betterle C, Greggio NA, Volpato M. Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 1998; 83: 1049-55.
- 13. Wolf ASB, Erichsen MM, Meager A, Magitta NF, Myhre AG, Bollerslev J. et al. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in autoimmune regulator gene. J Clin Endocrinol Metab 2007; 92: 595-603.
- 14. Zlotogora J, Shapiro MS. Polyglandular autoimmune syndrome type 1 among Iranian Jews. J Med Genet 1992; 29: 824-6.
- 15. Husebye ES, Perheentupa J, Rautemaa R, Kampe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med 2009; 265: 514-29.
- 16. Ward L, Paquette J, Seidman E, Huot C, Alvarez F, Crock P. et al. Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J Clin Endocrinol Metab 1999; 84: 844-52.
- 17. Pun T, Chandurkar V. Growth hormone deficiency, short stature, and juvenile rheumatoid arthritis in a patient with autoimmune polyglandular syndrome type 1: case report and brief review of the literature. ISRN Endocrinology 2011: 462759.
- 18. Högenauer C, Meyer RL, Netto GJ, Bell D, Little KH, Ferries L. et al. Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I. N Engl J Med 2001; 344: 270-4.
- 19. Scarpa R, Alaggio R, Norberto L, Furmaniak J, Chen S, Smith BR. et al.Tryptophan hydroxylase autoantibodies as markers of a distinct autoimmune gastrointestinal component of autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 2013; 98: 704-12.
- 20. Posovszky C, Lahr G, von Schnurbein J, Buderus S, Findeisen A, Schröder C. et al. Loss of enteroendocrine cells in autoimmunepolyendocrine- candidiasis-ectodermal-dystrophy (APECED) syndrome with gastrointestinal dysfunction. J Clin Endocrinol Metab 2012; 97: E292-300.
- 21. Padeh S, Theodor R, Jonas A, Passwell JH. Severe malabsorption in autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome successfully treated with immunosuppression. Arch Dis Child 1997; 76: 532-4.
- 22. Kluger N, Jokinen M, Krohn K, Rankl A. What is the burden of living with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) in 2012? A health-related quality-of-life assessement in Finnish patients. Clin Endocrinol 2013; 79: 134-41.
- 23. Scott HS, Heino M, Peterson P, Mittaz L, Lalioti MD, Betterle C. et al. Common mutations in autoimmune polyendocrinopathy-candidiasisectodermal dystrophy patients of different origins. Mol Endocrinol 1998; 12: 1112-9.
- 24. Cihakova D, Trebusak K, Heino M, Fadeyev V, Tiulpakov A, Battelino T. et al. Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED. Hum Mutat 2001; 18: 225-32.
- 25. Myhre AG, Halonen M, Eskelin P, Ekwall O, Hedstrand H, Rorsman F. et al. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway. Clin Endocrinol 2001; 54: 211-7.
- 26. Meloni A, Willcox N, Meager A, Atzeni M, Wolf ASB, Husebye ES. et al. Autoimmune poyglandular syndrome type 1: an extensive longitudinal study in Sardinian patients. J Clin Endocrinol Metab 2012; 97: 1114-24.
- 27. Wolff AS, Sarkadi AK, Maródi L, Kärner J, Orlova E, Oftedal BE. et al. Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood. J Clin Immunol 2013; 33: 1341-8.